[Trade-offs in oral drug product development].
Drug products are developed to meet multiple targets, thereby increasing their value. Pharmaceutical scientists encounter several trade-offs during the development of novel oral formulations. These trade-offs are generated by their desire to supply the highest possible quality products under the prevailing conditions of limited time and cost, and feasible options. When there are two incompatible factors, it is sometimes difficult to dismiss one element. This is because a quality target product profile (QTPP) is critical for each product being developed, and all elements should basically be satisfied with the criteria. Therefore, technological innovation becomes important to overcome the trade-offs. This article introduces examples of such innovations which have been successful in doing this, as well as some encountered in the oral formulation development and in the selection of proper dosage forms. Based on these examples, points to be considered in order to produce the drug product are thoroughly discussed.
Pharmaceutical Research and Technology Labs., Astellas Pharma Inc.
Hiromu
H
Kondo
Kazuhiro
K
Sako
D000284:Administration, Oral; D004304:Dosage Forms; D015195:Drug Design; D006801:Humans; D012995:Solubility
D004304:Dosage Forms